![1]()
News
COVID-19 shifts telehealth to the center of cardiology
March 25, 2020
A series of recent mandates aimed at addressing barriers to telehealth ‘have come in a time of desperation,’ one New York–based cardiologist says.
![1]()
News
Dramatic rise in hypertension-related deaths in the United States
March 20, 2020
The ‘alarming’ increase in hypertension-related deaths between 2007 and 2017, was particularly prominent in the rural South.
![1]()
News
AFib-related cardiovascular deaths on the rise
March 19, 2020
PHOENIX, ARIZ. – A more pronounced increase in mortality rate was observed among black and white men.
![1]()
News
COVID-19 will test medical supply stocks
March 19, 2020
“In the matter of a week or two...I think we’ll get a feel for whether or not we really have enough of the supplies that it takes,” said Dr. Anthony Fauci.
News
COVID-19: U.S. cardiology groups reaffirm continued use of RAAS-active drugs
March 18, 2020
Experts give ACE inhibitors and ARBs, cornerstones of cardiology therapy, a thumbs up despite a hypothetical adverse COVID-19 effect.
News
FDA advises stopping SGLT2 inhibitor treatment prior to surgery
March 18, 2020
The changes affect canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin, and were made because surgery may put patients taking SGLT2 inhibitors at a higher risk of ketoacidosis.
![1]()
News
PARAGON-HF: Optimal systolic pressure in HFpEF is 120-129 mm Hg
March 18, 2020
In largest-ever HFpEF trial, SBP of 120-129 mm Hg was associated with lowest cardiovascular risk.
![1]()
News
ICH survival lags in the community setting
March 17, 2020
LOS ANGELES – An observed 6-month mortality of 64% in a Dutch study contrasts with better survival in interventional trials.
![1]()
News
Trump to governors: Don’t wait for feds on medical supplies
March 16, 2020
President Trump outlined new guidance for Americans to avoid gatherings of more than 10 people.
News
ESC says continue hypertension meds despite COVID-19 concern
March 16, 2020
European Society of Cardiology cites lack of data for theoretical link between ACE inhibitors and ARBs with COVID-19 infection risk.
